Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
092076
Wellcome Trust - United Kingdom
Biotechnology and Biological Sciences Research Council - United Kingdom
Cancer Research UK - United Kingdom
PubMed
25543083
DOI
10.1016/j.jmb.2014.12.011
PII: S0022-2836(14)00645-7
Knihovny.cz E-resources
- Keywords
- MDM2, RING domain, allostery, linear motifs, ubiquitination,
- MeSH
- Allosteric Regulation MeSH
- Amino Acid Motifs MeSH
- Point Mutation * MeSH
- Hydrolysis MeSH
- Protein Conformation MeSH
- Humans MeSH
- Molecular Sequence Data MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Tumor Suppressor Protein p53 chemistry metabolism MeSH
- Polyubiquitin metabolism MeSH
- Proto-Oncogene Proteins c-mdm2 chemistry genetics metabolism MeSH
- Amino Acid Sequence MeSH
- Protein Structure, Tertiary MeSH
- Ubiquitin-Conjugating Enzymes metabolism MeSH
- Ubiquitin metabolism MeSH
- Ubiquitination MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Tumor Suppressor Protein p53 MeSH
- Polyubiquitin MeSH
- Proto-Oncogene Proteins c-mdm2 MeSH
- UBE2D1 protein, human MeSH Browser
- Ubiquitin-Conjugating Enzymes MeSH
- Ubiquitin MeSH
Mouse double minute 2 (MDM2) has a phosphorylation site within a lid motif at Ser17 whose phosphomimetic mutation to Asp17 stimulates MDM2-mediated polyubiquitination of p53. MDM2 lid deletion, but not Asp17 mutation, induced a blue shift in the λ(max) of intrinsic fluorescence derived from residues in the central domain including Trp235, Trp303, Trp323, and Trp329. This indicates that the Asp17 mutation does not alter the conformation of MDM2 surrounding the tryptophan residues. In addition, Phe235 mutation enhanced MDM2 binding to p53 but did not stimulate its ubiquitination function, thus uncoupling increases in p53 binding from its E3 ubiquitin ligase function. However, the Asp17 mutation in MDM2 stimulated its discharge of the UBCH5a-ubiquitin thioester adduct (UBCH5a is a ubiquitin-conjugating enzyme E2D 1 UBC4/5 homolog yeast). This stimulation of ubiquitin discharge from E2 was independent of the p53 substrate. There are now four known effects of the Asp17 mutation on MDM2: (i) it alters the conformation of the isolated N-terminus as defined by NMR; (ii) it induces increased thermostability of the isolated N-terminal domain; (iii) it stimulates the allosteric interaction of MDM2 with the DNA-binding domain of p53; and (iv) it stimulates a novel protein-protein interaction with the E2-ubiquitin complex in the absence of substrate p53 that, in turn, increases hydrolysis of the E2-ubiquitin thioester bond. These data also suggest a new strategy to disrupt MDM2 function by targeting the E2-ubiquitin discharge reaction.
Edinburgh Centre for Chemical Biology University of Edinburgh Edinburgh EH8 9YL United Kingdom
RECAMO Masaryk Memorial Cancer Institute 656 53 Brno Czech Republic
References provided by Crossref.org
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function